Sirolimus
Drug · tier A · 4 trials (1 recruiting) · 0 publications · score 30.5
Alemtuzumab
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 27.0
Tacrolimus Anhydrous
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 24.0
Anti-Thymocyte Globulin
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 21.0
Research map, not treatment advice. Built 2026-10-07.